论文部分内容阅读
目的:探讨硫酸镁治疗儿童哮喘的疗效。方法:将80例哮喘儿童分为两组,对照组常规使用甲基强的松龙、布地奈德、沙丁胺醇雾化吸入,治疗组在常规治疗的基础上,加用25%硫酸镁0.2 ml/kg静滴,比较两组的缓解率和复发率。结果:对照组38例,20例3天内完全缓解,占52.6%,10例5天内缓解,占26.3%,8例反复发作,其中5例第9日缓解,3例12天缓解。治疗组42例,30例3天内完全缓解,占71.4%,8例5天内缓解,占19.0%,4例1周后缓解。结论:在常规使用甲基强的松龙、布地奈德、沙丁胺醇雾化吸入的基础上,加用硫酸镁治疗支气管哮喘可提高疗效,缩短缓解的时间。
Objective: To investigate the therapeutic effect of magnesium sulfate on childhood asthma. Methods: Eighty asthmatic children were divided into two groups. The control group was given routine inhalation of methylprednisolone, budesonide, and salbutamol. The treatment group was treated with 25% magnesium sulfate 0.2 ml / kg intravenous infusion, compared the two groups of remission rate and recurrence rate. Results: In the control group, 38 cases were treated with complete remission in 20 cases within 3 days, 52.6% within 10 days, 10 cases within 5 days, accounting for 26.3% and 8 cases recurrent. Among them, 5 cases were relieved on the 9th day and 3 days were relieved on the 12th day. The treatment group of 42 patients, 30 cases of complete remission within 3 days, accounting for 71.4%, 8 cases of 5 days to ease, accounting for 19.0%, 4 cases of remission after 1 week. Conclusion: In the routine use of methylprednisolone, budesonide, salbutamol inhalation based on the addition of magnesium sulfate treatment of bronchial asthma can improve the curative effect and shorten the time of remission.